• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病诊断前数十年心血管疾病事件增加两倍:一项全国登记研究。

2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study.

机构信息

Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

出版信息

J Am Coll Cardiol. 2024 Dec 3;84(23):2251-2259. doi: 10.1016/j.jacc.2024.06.050.

DOI:10.1016/j.jacc.2024.06.050
PMID:39603746
Abstract

BACKGROUND

The risk of cardiovascular disease (CVD) is increased in individuals with type 2 diabetes mellitus (T2DM), but it remains uncertain how long an elevated CVD occurrence precedes diabetes diagnosis.

OBJECTIVES

The aim of this study was to investigate CVD occurrence 30 years before, and 5 years after, T2DM diagnosis compared with matched comparisons.

METHODS

This combined case-control and cohort study included all individuals diagnosed with T2DM in Denmark between 2010 and 2015, as well as general population comparisons matched by age and sex. CVD was defined as myocardial infarction or ischemic stroke. Conditional logistic regression was used to compute ORs for CVD prevalence in the 30-year period before T2DM diagnosis. Cox proportional hazards regression models were used to compute HRs for 5-year CVD incidence after T2DM diagnosis.

RESULTS

The study included 127,092 individuals with T2DM and 381,023 matched comparisons. In the 30-year period before T2DM diagnosis, 14,179 (11.2%) T2DM individuals and 17,871 (4.7%) comparisons experienced CVD. CVD prevalence was higher in those with T2DM than the comparisons in the entire period before T2DM diagnosis, with ORs ranging from 2.18 (95% CI: 1.91-2.48) in the earliest period (25-30 years before diagnosis) to 2.96 (95% CI: 2.85-3.08) in the latest period (<5 years before diagnosis). After T2DM diagnosis, 5-year CVD incidence was similarly increased in T2DM individuals vs comparisons (HR: 2.20; 95% CI: 2.12-2.27).

CONCLUSIONS

Individuals with T2DM had 2-fold more CVD events than matched comparisons starting 3 decades before T2DM diagnosis. This indicates that comprehensive preventive strategies may be initiated much earlier in individuals at risk of T2DM.

摘要

背景

2 型糖尿病(T2DM)患者发生心血管疾病(CVD)的风险增加,但尚不清楚 CVD 的发生时间早于糖尿病诊断多长时间。

目的

本研究旨在调查 T2DM 诊断前 30 年和诊断后 5 年与匹配对照相比 CVD 的发生情况。

方法

本项病例对照和队列研究纳入了 2010 年至 2015 年期间在丹麦被诊断为 T2DM 的所有患者以及年龄和性别相匹配的一般人群对照。CVD 定义为心肌梗死或缺血性卒中。采用条件 logistic 回归计算 T2DM 诊断前 30 年 CVD 患病率的比值比(OR)。采用 Cox 比例风险回归模型计算 T2DM 诊断后 5 年 CVD 发生率的 HR。

结果

本研究共纳入了 127092 例 T2DM 患者和 381023 例匹配对照。在 T2DM 诊断前 30 年期间,14179 例(11.2%)T2DM 患者和 17871 例(4.7%)对照发生了 CVD。在整个 T2DM 诊断前期间,T2DM 患者的 CVD 患病率均高于对照,OR 范围从最早时期(诊断前 25-30 年)的 2.18(95%CI:1.91-2.48)到最晚时期(<5 年)的 2.96(95%CI:2.85-3.08)。在 T2DM 诊断后,T2DM 患者与对照相比,5 年 CVD 发生率也明显增加(HR:2.20;95%CI:2.12-2.27)。

结论

T2DM 患者在 T2DM 诊断前 30 年就发生 CVD 的风险是匹配对照的 2 倍。这表明在 2 型糖尿病高危人群中,可能更早启动综合预防策略。

相似文献

1
2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study.2 型糖尿病诊断前数十年心血管疾病事件增加两倍:一项全国登记研究。
J Am Coll Cardiol. 2024 Dec 3;84(23):2251-2259. doi: 10.1016/j.jacc.2024.06.050.
2
10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus.新诊断 2 型糖尿病患者的 10 年心血管风险。
J Am Coll Cardiol. 2023 Oct 17;82(16):1583-1594. doi: 10.1016/j.jacc.2023.08.015.
3
Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.2 型糖尿病发病年龄与心血管风险和死亡风险的关系。
Circulation. 2019 May 7;139(19):2228-2237. doi: 10.1161/CIRCULATIONAHA.118.037885.
4
Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study.新诊断为 2 型糖尿病且正在接受他汀类药物治疗的患者的甘油三酯与心血管事件风险:一项丹麦队列研究。
Cardiovasc Diabetol. 2023 Jul 26;22(1):187. doi: 10.1186/s12933-023-01921-5.
5
Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.2 型糖尿病患者的心血管事件和血管介入发生率。
Int J Cardiol. 2017 Dec 1;248:301-307. doi: 10.1016/j.ijcard.2017.07.081. Epub 2017 Jul 23.
6
All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease.根据 2 型糖尿病状态和已确立的心血管疾病,对西班牙高龄人群的全因死亡率和心血管事件进行分析。
BMC Geriatr. 2022 Mar 18;22(1):224. doi: 10.1186/s12877-022-02893-z.
7
Diabetic retinopathy as an independent marker of cardiovascular disease in type 1 diabetes: Results from a nationwide longitudinal matched case-cohort study.1 型糖尿病患者的糖尿病视网膜病变作为心血管疾病的独立标志物:来自全国性纵向匹配病例对照研究的结果。
Acta Ophthalmol. 2024 Sep;102(6):635-642. doi: 10.1111/aos.16653. Epub 2024 Feb 12.
8
Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019.2012 年至 2019 年丹麦全国队列研究:2 型糖尿病和心血管疾病患者心脏保护降糖药物的真实世界应用。
Diabetes Obes Metab. 2021 Feb;23(2):520-529. doi: 10.1111/dom.14245. Epub 2020 Nov 17.
9
The relationships between biological novel biomarkers Lp-PLA and CTRP-3 and CVD in patients with type 2 diabetes mellitus.生物新型标志物 Lp-PLA2 和 CTRP-3 与 2 型糖尿病患者 CVD 的关系。
J Diabetes. 2024 Jul;16(7):e13574. doi: 10.1111/1753-0407.13574.
10
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.1型糖尿病与2型糖尿病患者心血管和肾脏疾病的患病率及发病率:一项法国全国性住院患者观察性研究
Diabetes Metab. 2023 May;49(3):101429. doi: 10.1016/j.diabet.2023.101429. Epub 2023 Feb 1.

引用本文的文献

1
Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure.钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂对心力衰竭生物标志物的影响
Cells. 2025 Jun 18;14(12):919. doi: 10.3390/cells14120919.
2
Time Trends in Cardiovascular Event Incidence in New-Onset Type 2 Diabetes: A Population-Based Cohort Study From Germany.新发2型糖尿病患者心血管事件发生率的时间趋势:一项基于德国人群的队列研究
J Diabetes. 2025 Jun;17(6):e70099. doi: 10.1111/1753-0407.70099.
3
Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study.
在超重和肥胖的貌似健康个体中,肝脂肪变性与纤溶酶原激活物抑制剂-1呈正相关:一项基于FibroScan的横断面研究。
J Transl Med. 2025 Apr 29;23(1):487. doi: 10.1186/s12967-025-06464-9.
4
Cardiovascular abnormalities already occurred in newly-diagnosed patients with early-onset type 2 diabetes.心血管异常已经在新诊断的早发型2型糖尿病患者中出现。
Cardiovasc Diabetol. 2025 Mar 26;24(1):140. doi: 10.1186/s12933-025-02665-0.
5
Incidence and Risk Factors for Developing Type 2 Diabetes Mellitus After Acute Myocardial Infarction-A Long-Term Follow-Up.急性心肌梗死后发生2型糖尿病的发病率及危险因素——一项长期随访研究
J Cardiovasc Dev Dis. 2025 Feb 28;12(3):89. doi: 10.3390/jcdd12030089.